SynKIR-310 for Relapsed/Refractory B-NHL
Verismo Therapeutics
Verismo Therapeutics
ModeX Therapeutics, An OPKO Health Company
Eli Lilly and Company
Mayo Clinic
ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA)
City of Hope Medical Center
Nkarta, Inc.
Taproot Health
Scripps Health
Rutgers, The State University of New Jersey
Roswell Park Cancer Institute
Roswell Park Cancer Institute
Masonic Cancer Center, University of Minnesota
Roswell Park Cancer Institute
Case Comprehensive Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Roswell Park Cancer Institute
Fred Hutchinson Cancer Center
University of Maryland, Baltimore
University of Maryland, Baltimore
Roswell Park Cancer Institute
University of Chicago
Case Comprehensive Cancer Center
Fred Hutchinson Cancer Center
Masonic Cancer Center, University of Minnesota
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
UNC Lineberger Comprehensive Cancer Center
Wake Forest University Health Sciences
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Vanderbilt University Medical Center
Alliance for Clinical Trials in Oncology
Barbara Ann Karmanos Cancer Institute
Morphotek
Rutgers, The State University of New Jersey
Eastern Cooperative Oncology Group
Case Comprehensive Cancer Center
Cellerant Therapeutics
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
National Cancer Institute (NCI)
INSYS Therapeutics Inc
National Cancer Institute (NCI)
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)